Gilead expands lenacapavir licensing to cover once-yearly HIV prevention
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Gilead Sciences (NASDAQ: GILD) | Delayed: 152.94 -3.57 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.51 | 52 Week High | $108.63 | |||
| Open | $154.73 | 52 Week Low | $71.39 | |||
| Day High | $155.42 | P/E | 84.50 | |||
| Day Low | $151.71 | EPS | $1.81 | |||
| Volume | 2,559,656 | |||||
